UAE to trial Sinopharm COVID-19 vaccine in children aged 3 to 17
- Date: 10-Jun-2021
- Source: Gulf Insider
- Sector:Healthcare
- Country:UAE
UAE to trial Sinopharm COVID-19 vaccine in children aged 3 to 17
The UAE's Ministry of Health and Prevention (MOHAP) has initiated a Sinopharm ‘immune bridge study' for children aged three to 17 years.
The UAE is the first country in the Middle East and North Africa region to conduct a study of the vaccine's effectiveness for this age group.
The study's preliminary results will be announced once available, and will support the planning process for the safe return to schools.
Select Sector 
Select Country 
